# An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes

> **NCT01817777** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 31 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Metformin Small Pack
- **DRUG:** Metformin Large Pack

## Key facts

- **NCT ID:** NCT01817777
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** It's no longer feasible to continue to recruit patients into the study as severe recruitment difficulties have been experienced since the study start
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817777, "An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01817777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*